Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Dexbrompheniramine
2. Disophrol
1. 2391-03-9
2. Disomer
3. (+)-brompheniramine Maleate
4. (s)-brompheniramine Maleate
5. Brompheniramine D-form Maleate
6. Chebi:59273
7. Dexbrompheniramine Fumarate
8. Bpa9ut29bs
9. 2391-03-9 (maleate)
10. Dsstox_cid_27795
11. Dsstox_rid_82567
12. Dsstox_gsid_47818
13. Dexbrompheniramine Maleate (usp)
14. Dexbrompheniramine Maleate [usp]
15. Disomer Maleate
16. (3s)-3-(4-bromophenyl)-n,n-dimethyl-3-pyridin-2-ylpropan-1-amine Maleate
17. 2-pyridinepropanamine, G-(4-bromophenyl)-n,n-dimethyl-, (gs)-,(2z)-2-butenedioate (1:1)
18. Cas-2391-03-9
19. Ncgc00162100-02
20. Alahist Ir
21. Alahist Pe
22. Disomer (tn)
23. D-brompheniramine Maleate
24. Unii-bpa9ut29bs
25. Mls001401374
26. Schembl217770
27. 3-(2-hydroxyphenyl)benzoicacid
28. Chembl1200638
29. Dtxsid6047818
30. (+)-brompheniramine Maleate Salt
31. Hms2051f10
32. Hms2235o07
33. Hms3260p05
34. Einecs 219-236-2
35. Tox21_112000
36. Tox21_500232
37. Bdbm50247924
38. Akos015962824
39. Tox21_112000_1
40. Ac-1161
41. Ccg-101017
42. Lp00232
43. Nc00267
44. Ncgc00015146-11
45. Ncgc00093697-01
46. Ncgc00260917-01
47. Dexbrompheniramine Maleate [mart.]
48. Dexbrompheniramine Maleate [vandf]
49. Smr000471616
50. Dexbrompheniramine Maleate [usp-rs]
51. Dexbrompheniramine Maleate [who-dd]
52. Brompheniramine D-form Maleate [mi]
53. Eu-0100232
54. B 5275
55. D03704
56. Dexbrompheniramine Maleate [orange Book]
57. Dexbrompheniramine Maleate [usp Monograph]
58. Sr-01000075719
59. Disobrom Component Dexbrompheniramine Maleate
60. Disophrol Component Dexbrompheniramine Maleate
61. Drixoral Component Dexbrompheniramine Maleate
62. Resporal Component Dexbrompheniramine Maleate
63. Sr-01000075719-1
64. Brompheril Component Dexbrompheniramine Maleate
65. Dexbrompheniramine Maleate Component Of Disobrom
66. Dexbrompheniramine Maleate Component Of Drixoral
67. Dexbrompheniramine Maleate Component Of Resporal
68. Q27126583
69. Dexbrompheniramine Maleate Component Of Brompheril
70. Dexbrompheniramine Maleate Component Of Disophrol
71. Drixoral Plus Component Dexbrompheniramine Maleate
72. Dexbrompheniramine Maleate Component Of Drixoral Plus
73. (+)-2-(p-bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine Maleate
74. (s)-1-(p-bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane Maleate
75. (s)-2-(p-bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine Maleate
76. (+)-2-(p-bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine Maleate
77. (+)-3-(4-bromophenyl)-n,n-dimethyl-3-(2-pyridinyl)-1-propanamine Maleate
78. (+)-3-(p-bromophenyl)-3-(2-pyridyl)-n,n-dimethylpropylamine Maleate
79. (s)-3-(4-bromophenyl)-n,n-dimethyl-3-(2-pyridinyl)-1-propanamine Maleate
80. (s)-3-(p-bromophenyl)-3-(2-pyridyl)-n,n-dimethylpropylamine Maleate
81. (+)-2-(p-bromo-.alpha.-(2-(dimethylamino)ethyl)benzyl)pyridine Maleate (1:1)
82. (+)-2-(p-bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine Maleate (1:1)
83. (+)-3-(4-bromophenyl)-n,n-dimethyl-3-(pyridin-2-yl)propan-1-amine Maleate
84. (3s)-3-(4-bromophenyl)-n,n-dimethyl-3-(pyridin-2-yl)propan-1-amine (2z)-but-2-enedioate
85. (3s)-3-(4-bromophenyl)-n,n-dimethyl-3-(pyridin-2-yl)propan-1-amine Maleate
86. (3s)-3-(4-bromophenyl)-n,n-dimethyl-3-pyridin-2-ylpropan-1-amine;(z)-but-2-enedioic Acid
87. (s)-2-(p-bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridinium (z)-maleate (1:1)
88. (s)-3-(4-bromophenyl)-n,n-dimethyl-3-(pyridin-2-yl)propan-1-amine Maleate
89. Dexbrompheniramine Maleate, United States Pharmacopeia (usp) Reference Standard
90. Pyridine, 2-(p-bromo-alpha-(2-(dimethylamino)ethyl)benzyl)-, Maleate (1:1), (s)-
91. 2-pyridinepropanamine, G-(4-bromophenyl)-n,n-dimethyl-, (s)-, (z)-2-butenedioate (1:1)
92. 2-pyridinepropanamine, Gamma-(4-bromophenyl)-n,n-dimethyl-, (s)-, (z)-2-butenedioate (1:1)
Molecular Weight | 435.3 g/mol |
---|---|
Molecular Formula | C20H23BrN2O4 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 7 |
Exact Mass | 434.08412 g/mol |
Monoisotopic Mass | 434.08412 g/mol |
Topological Polar Surface Area | 90.7 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 368 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Histamine H1 Antagonists
Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8625
Submission : 1990-06-28
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4799
Submission : 1982-11-22
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5669
Submission : 1985-01-04
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4312
Submission : 1981-10-21
Status : Inactive
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7652
Submission : 1988-08-26
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info : DISCN
Registration Country : USA
DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE
Brand Name : DEXBROMPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE SULFATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 6MG;120MG
Packaging :
Approval Date : 2013-02-27
Application Number : 78648
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DISOMER
Dosage Form : TABLET;ORAL
Dosage Strength : 2MG
Packaging :
Approval Date : 1982-01-01
Application Number : 11814
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DISOMER
Dosage Form : SYRUP;ORAL
Dosage Strength : 2MG/5ML
Packaging :
Approval Date : 1982-01-01
Application Number : 11814
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE
Brand Name : DISOPHROL
Dosage Form : TABLET;ORAL
Dosage Strength : 2MG;60MG
Packaging :
Approval Date : 1982-01-01
Application Number : 12394
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE
Brand Name : BROMPHERIL
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 6MG;120MG
Packaging :
Approval Date : 1987-01-22
Application Number : 89116
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE
Brand Name : DRIXORAL
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 6MG;120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-09-13
Application Number : 13483
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE
Brand Name : DISOPHROL
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 6MG;120MG
Packaging :
Approval Date : 1982-09-13
Application Number : 13483
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ACETAMINOPHEN; DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE
Brand Name : DRIXORAL PLUS
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 500MG;3MG;60MG
Packaging :
Approval Date : 1987-05-22
Application Number : 19453
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE
Brand Name : RESPORAL
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 6MG;120MG
Packaging :
Approval Date : 1988-06-16
Application Number : 89139
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE
Brand Name : DISOBROM
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 6MG;120MG
Packaging :
Approval Date : 1991-09-30
Application Number : 70770
Regulatory Info : DISCN
Registration Country : USA
RLD : No
TE Code :
DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE
Brand Name : DEXBROMPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE SULFATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 6MG;120MG
Approval Date : 2013-02-27
Application Number : 78648
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : DISOMER
Dosage Form : TABLET;ORAL
Dosage Strength : 2MG
Approval Date : 1982-01-01
Application Number : 11814
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : DISOMER
Dosage Form : SYRUP;ORAL
Dosage Strength : 2MG/5ML
Approval Date : 1982-01-01
Application Number : 11814
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE
Brand Name : DISOPHROL
Dosage Form : TABLET;ORAL
Dosage Strength : 2MG;60MG
Approval Date : 1982-01-01
Application Number : 12394
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE
Brand Name : BROMPHERIL
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 6MG;120MG
Approval Date : 1987-01-22
Application Number : 89116
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : Yes
TE Code :
DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE
Brand Name : DRIXORAL
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 6MG;120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date : 1982-09-13
Application Number : 13483
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : No
TE Code :
DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE
Brand Name : DISOPHROL
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 6MG;120MG
Approval Date : 1982-09-13
Application Number : 13483
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
ACETAMINOPHEN; DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE
Brand Name : DRIXORAL PLUS
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 500MG;3MG;60MG
Approval Date : 1987-05-22
Application Number : 19453
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE
Brand Name : RESPORAL
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 6MG;120MG
Approval Date : 1988-06-16
Application Number : 89139
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE
Brand Name : DISOBROM
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 6MG;120MG
Approval Date : 1991-09-30
Application Number : 70770
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Related Excipient Companies
Dosage Form : Capsule
Grade : Oral
Application : Controlled & Modified Release
Excipient Details : EUDRAGIT® L 100, a functional delayed release polymer is used to increase solubility of poorly soluble products such as tablets, capsules, ODTs, etc.
Pharmacopoeia Ref : NA
Technical Specs : Available as powder; Other grades- EUDRAGIT® L 12,5
Ingredient(s) : METHACRYLIC ACID COPOLYMER TYPE A
Excipients by Applications
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?